ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Eur Respir J 2006; 27:108-113
Copyright ©ERS Journals Ltd 2006
doi: 10.1183/09031936.06.00054105

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabiller, A.
Right arrow Articles by Humbert, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabiller, A.
Right arrow Articles by Humbert, M.

Occult alveolar haemorrhage in pulmonary veno-occlusive disease

A. Rabiller1, X. Jaïs1, A. Hamid1, A. Resten2, F. Parent1, R. Haque1, F. Capron3, O. Sitbon1, G. Simonneau1 and M. Humbert1

1 Centre des Maladies Vasculaires Pulmonaires, Service de Pneumologie. 2 Service de Radiologie, and 3 Service d'Anatomie Pathologique, Unité Propre de Recherche de l'Enseignement Supérieur EA2705, Hôpital Antoine Béclère, Université Paris-Sud, Clamart, France.

CORRESPONDENCE: M. Humbert, Service de Pneumologie, Hôpital Antoine Béclère, 157, Rue de la Porte de Trivaux, 92140 Clamart, France. Fax: 33 146303824. E-mail: marc.humbert{at}abc.aphp.fr

Keywords: Alveolar haemorrhage, bronchoalveolar lavage, pulmonary arterial hypertension, pulmonary veno-occlusive disease

Received: May 6, 2005
Accepted August 23, 2005

Pulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary arterial hypertension that affects predominantly post-capillary pulmonary vessels. A major concern with PVOD is the poor response to available therapies and the risk of pulmonary oedema with continuous intravenous epoprostenol.

The present authors hypothesised that alveolar haemorrhage may be a characteristic feature of pulmonary veno-occlusive disease, as compared with other forms of pulmonary arterial hypertension that predominantly involve pre-capillary pulmonary arteries.

This paper reports a series of 19 patients with either PVOD (n = 8) or idiopathic pulmonary arterial hypertension (IPAH; n = 11) who underwent bronchoalveolar lavage. Cytological analyses were performed and differential counts were made on Perls-stained preparations. The Golde score was used to assess alveolar haemorrhage. As compared with IPAH, PVOD was characterised by a higher percentage of haemosiderin-laden macrophages (40±37 versus 3±6%), resulting in elevated Golde scores (81±88 versus 4±10).

It was concluded that occult alveolar haemorrhage is a common feature of pulmonary veno-occlusive disease. Detecting occult alveolar haemorrhage may be of interest in the diagnostic approach of pulmonary veno-occlusive disease.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
P. Dorfmuller, D. Montani, and M. Humbert
Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Eur. Respir. J., January 1, 2010; 35(1): 6 - 8.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Montani, X. Jais, L. C. Price, L. Achouh, B. Degano, O. Mercier, S. Mussot, E. Fadel, P. Dartevelle, O. Sitbon, et al.
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease
Eur. Respir. J., December 1, 2009; 34(6): 1348 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
The Task Force for the Diagnosis and Treatment of, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension
Eur. Respir. J., December 1, 2009; 34(6): 1219 - 1263.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Montani, X. Jais, P. Dorfmuller, G. Simonneau, O. Sitbon, and M. Humbert
Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution
Eur. Respir. J., November 1, 2009; 34(5): 1204 - 1206.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537.
[Full Text] [PDF]

Home page
 ChestHome page
D. Montani, L. Achouh, O. Sitbon, G. Simonneau, and M. Humbert
Pulmonary Venoocclusive Disease and Failure of Specific Therapy
Chest, October 1, 2009; 136(4): 1181 - 1181.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
R. M. Jones, A. Dawson, G. H. Jenkins, A. G. Nicholson, D. M. Hansell, and N. K. Harrison
Sarcoidosis-related pulmonary veno-occlusive disease presenting with recurrent haemoptysis
Eur. Respir. J., August 1, 2009; 34(2): 517 - 520.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. J. Overbeek, M. C. Vonk, A. Boonstra, A. E. Voskuyl, A. Vonk-Noordegraaf, E. F. Smit, B. A. C. Dijkmans, P. E. Postmus, W. J. Mooi, Y. Heijdra, et al.
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Eur. Respir. J., August 1, 2009; 34(2): 371 - 379.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. Simonneau, I. M. Robbins, M. Beghetti, R. N. Channick, M. Delcroix, C. P. Denton, C. G. Elliott, S. P. Gaine, M. T. Gladwin, Z.-C. Jing, et al.
Updated clinical classification of pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S43 - S54.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
H. Khaldi, S. Marchand-Adam, C. Kannengiesser, A. Fabre, M. P. Debray, C. Danel, M-A. Gougerot-Pocidalo, J. El Benna, M. Humbert, M. Aubier, et al.
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease
Eur. Respir. J., June 1, 2009; 33(6): 1498 - 1502.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Humbert
Update in Pulmonary Hypertension 2008
Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 650 - 656.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
D. Montani, L. C. Price, P. Dorfmuller, L. Achouh, X. Jais, A. Yaici, O. Sitbon, D. Musset, G. Simonneau, and M. Humbert
Pulmonary veno-occlusive disease
Eur. Respir. J., January 1, 2009; 33(1): 189 - 200.
[Abstract] [Full Text] [PDF]

Home page
 ACCP Pulmonary Med Brd RevHome page
U. Specks
Pulmonary Vasculitis and Alveolar Hemorrhage Syndromes
ACCP Pulmonary Med Brd Rev, January 1, 2009; 25(0): 687 - 704.
[Full Text] [PDF]

Home page
 HeartHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Heart, March 1, 2008; 94(Suppl_1): i1 - i41.
[Full Text] [PDF]

Home page
 ThoraxHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
M. M. Hoeper and A. T. Dinh-Xuan
Pulmonary hypertension: basic concepts and practical management
Eur. Respir. J., February 1, 2008; 31(2): 236 - 237.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.